We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

70 hedge funds and large institutions have $54.9M invested in Histogen Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

71% more call options, than puts

Call options by funds: $549K | Put options by funds: $321K

29% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 21

10% less capital invested

Capital invested by funds: $60.8M → $54.9M (-$5.92M)

10% less funds holding

Funds holding: 7870 (-8)

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
70
Holders Change
-8
Holders Change %
-10.26%
% of All Funds
1.59%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
7
Increased
27
Reduced
21
Closed
15
Calls
$549K
Puts
$321K
Net Calls
+$228K
Net Calls Change
+$157K

HSTO Hedge Fund Activity: Q4 2017 in Review

70 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2017, worth a combined $54.9M — down 9.7% from $60.8M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of HSTO and 7 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 27 added.

The largest buyer was MPM Asset Management, adding an estimated $4.2M. The largest seller was Numeric Investors, exiting entirely with an estimated $1.43M sold.

  • 70 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2017, down from 78 in Q3 2017.
  • Funds reported $54.9M of Histogen Inc. Common Stock stock for Q4 2017, down 9.7% quarter-over-quarter.
  • 7 funds opened new Histogen Inc. Common Stock positions in Q4 2017 and 15 closed out, a net change of -8 holders.
  • The largest Histogen Inc. Common Stock buyer in Q4 2017 was MPM Asset Management, an estimated $4.2M added.
  • The largest Histogen Inc. Common Stock seller in Q4 2017 was Numeric Investors, an estimated $1.43M sold.

Based on aggregated 13F filings for Q4 2017.